The Nikolai Gamaleya National Research Center, the developer of the vaccine, confirmed on Tuesday the high quality of the batch prepared by the Argentinean laboratory as a test and sent for review in Russia.
The Argentinean representative in Moscow told Sputnik news agency at the International Economic Forum in Saint Petersburg (Spief 2021) that the next stage will be the import of antigens, a step to be taken in the near future.
Zuain stressed that despite the pandemic, Argentina and Russia are now experiencing ‘an excellent time in bilateral relations’ and highly valued the cooperation between the two states in the fight against Covid-19.
In this regard, he underscored the supply of the Sputnik V vaccine to Argentina, as well as the transfer of Russian technology for its manufacture.
Zuain recalled that he is not only interested in manufacturing the Russian vaccine for its use in Argentina, but also to export it to Latin America.